US$ 25.45
glp 1 receptor agonists in idiopathic intracranial hypertension GLP-1 medications and pseudotumor cerebri / #pseudotumorcerebri #iih Efficacy of glucagon-like peptide-1 receptor
Description
If you have specific concerns or a situation arises in which you require medical advice, you should consult with an appropriately trained and qualified medical services provider.

doi: 10.1056/NEJMoa1411892

They come with a US Boxed Warning of a risk of thyroid C-cell tumors and medullary thyroid carcinoma and are contraindicated in patients with multiple endocrine neoplasia syndrome type 2

(Lausanne) 13 , 934775 (2022)
